Skip to main content

Leading the Future of Cancer Testing

The Clinical Trial Testing Partner at Peter Mac - Australia's most comprehensive, full-service, cancer testing laboratory, offering cutting-edge solutions to support all stages of clinical development and support.

One Lab. Comprehensive Oncology Solutions. Clinical Excellence.

Nexomics is an expert contract service provider offering comprehensive, specialised oncology testing solutions.

Our services are powered by Peter MacCallum Cancer Centre, backed by pathologists, driven by our expert scientific & dedicated clinical trial team.

Together we support CROs, clinical and academic researchers, pharmaceutical and biotechnology clients through all stages of clinical development from early to late-stage clinical studies (Phase I to IV).

Our team operate from our integrated state-of-the-art NATA ISO/IEC 17025 and 15189 accredited laboratories. Here we harness cutting-edge technologies across all areas of clinical pathology with specialised genomics testing & clinical trial support services at the forefront of our comprehensive clinical trial testing solutions.

End-to-End Pathology and Clinical Trial Services

Your go-to partner for specialised cancer testing services, leveraging the expertise of the Peter MacCallum Cancer Centre. Our team of pathologists, scientists and clinical trial experts collaborate with CROs, researchers, and biotech firms to support every phase of clinical development.

Powered by Peter MacCallum Cancer Centre. Delivered by nexomics.

Anatomical Pathology

Delivering precise histological and immunohistochemical services tailored for cancer.

  • Histopathology (tissue processing, sectioning and special stains)
  • Immunohistochemistry (IHC) and In-situ hybridisation (ISH)
  • Digital Pathology (digital slide imaging) and second opinion services

Centralised Sample Processing

Ensuring the integrity of your biomarker assay data through robust, standardised procedures for various sample types including:

  • Blood sample processing (serum, plasma, buffy coat)
  • PBMC & BMMC isolation
  • DNA & RNA extraction
  • ctDNA extraction

Clinical Trial Services

Optimising diagnostic workflows with a centralised service designed to deliver efficiency and precision including:

  • Sample collection, management, storage and logistics
  • Preparation of laboratory manuals
  • Collection kit production and global supply

Haematopathology

Delivering a comprehensive evaluation of bone marrow samples enabling accurate diagnosis and management of complex benign and haematological malignancies and relevant prognostic information including:

  • Sample processing and staining of bone marrow aspirates and trephine biopsies.
  • Clinical reporting adhering to the guidelines of the International Council for Standardization in Haematology (ICSH).
  • Supplementary testing including both sequencing and flow cytometric methodologies  

Immuno-oncology

Supporting precision medicine with tailored immunological insights using cutting edge flow cytometry and immunology techniques.

  • Flow cytometry (immunophenotyping, cell viability and functional assays)
  • Soluble markers (ELISA and multiplex immunoassays)

Molecular Pathology

Enabling precision oncology through comprehensive genomic insights spanning clinical diagnostic testing including:

  • Chromogenic and fluorescent in-situ hybridisation (FISH)
  • Real-time PCR, qPCR and ddPCR
  • Sequencing - including Sanger and Next-GenerationSequencing (NGS)
  • Liquid biopsy testing (ctDNA)
  • Clinical diagnostic testing (Familial Cancer Predisposition, Molecular Oncology and Molecular Haematology)

Engage with our team to leverage precision cancer diagnostics to facilitate the advancement of your clinical trial. Our team will work to deliver retrospective and prospective testing within your specified timeline. A premium comprehensive service, delivered by nexomics.

Your Clinical Trial Testing Partner at Peter MacCallum Cancer Centre - nexomics

specialised oncology. an extensive Test Catalogue.

Transforming Clinical Translation. Empowering Genomics Medicine.

With our unique lab-to-bedside model, combined with our clinical and scientific expertise, we support the implementation of novel tests and technologies, serving as a key partner in clinical development, translation and diagnostics with a comprehensive oncology test offering.

Next up

End-to-End Pathology Services